Cargando…

SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study

BACKGROUND: Ethnic and religious minorities have been disproportionately affected by SARS-CoV-2 worldwide. The UK strictly-Orthodox Jewish community has been severely affected by the pandemic. This group shares characteristics with other ethnic minorities including larger family sizes, higher rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaskell, Katherine M, Johnson, Marina, Gould, Victoria, Hunt, Adam, Stone, Neil RH, Waites, William, Kasstan, Ben, Chantler, Tracey, Lal, Sham, Roberts, Chrissy H., Goldblatt, David, Eggo, Rosalind M, Marks, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/
https://www.ncbi.nlm.nih.gov/pubmed/34308409
http://dx.doi.org/10.1016/j.lanepe.2021.100127
_version_ 1783724571443068928
author Gaskell, Katherine M
Johnson, Marina
Gould, Victoria
Hunt, Adam
Stone, Neil RH
Waites, William
Kasstan, Ben
Chantler, Tracey
Lal, Sham
Roberts, Chrissy H.
Goldblatt, David
Eggo, Rosalind M
Marks, Michael
author_facet Gaskell, Katherine M
Johnson, Marina
Gould, Victoria
Hunt, Adam
Stone, Neil RH
Waites, William
Kasstan, Ben
Chantler, Tracey
Lal, Sham
Roberts, Chrissy H.
Goldblatt, David
Eggo, Rosalind M
Marks, Michael
author_sort Gaskell, Katherine M
collection PubMed
description BACKGROUND: Ethnic and religious minorities have been disproportionately affected by SARS-CoV-2 worldwide. The UK strictly-Orthodox Jewish community has been severely affected by the pandemic. This group shares characteristics with other ethnic minorities including larger family sizes, higher rates of household crowding and relative socioeconomic deprivation. We studied a UK strictly-Orthodox Jewish population to understand transmission of COVID-19 within this community. METHODS: We performed a household-focused cross-sectional SARS-CoV-2 serosurvey between late-October and early December 2020 prior to the third national lockdown. Randomly-selected households completed a standardised questionnaire and underwent serological testing with a multiplex assay for SARS-CoV-2 IgG antibodies. We report clinical illness and testing before the serosurvey, seroprevalence stratified by age and sex. We used random-effects models to identify factors associated with infection and antibody titres. FINDINGS: A total of 343 households, consisting of 1,759 individuals, were recruited. Serum was available for 1,242 participants. The overall seroprevalence for SARS-CoV-2 was 64.3% (95% CI 61.6-67.0%). The lowest seroprevalence was 27.6% in children under 5 years and rose to 73.8% in secondary school children and 74% in adults. Antibody titres were higher in symptomatic individuals and declined over time since reported COVID-19 symptoms, with the decline more marked for nucleocapsid titres. INTERPRETATION: In this tight-knit religious minority population in the UK, we report one of the highest SARS-CoV-2 seroprevalence levels in the world to date, which was markedly higher than the reported 10% seroprevalence in London at the time of the study. In the context of this high force of infection, all age groups experienced a high burden of infection. Actions to reduce the burden of disease in this and other minority populations are urgently required. FUNDING: This work was jointly funded by UKRI and NIHR [COV0335; MR/V027956/1], a donation from the LSHTM Alumni COVID-19 response fund, HDR UK, the MRC and the Wellcome Trust.
format Online
Article
Text
id pubmed-8291041
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82910412021-07-23 SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study Gaskell, Katherine M Johnson, Marina Gould, Victoria Hunt, Adam Stone, Neil RH Waites, William Kasstan, Ben Chantler, Tracey Lal, Sham Roberts, Chrissy H. Goldblatt, David Eggo, Rosalind M Marks, Michael Lancet Reg Health Eur Research Paper BACKGROUND: Ethnic and religious minorities have been disproportionately affected by SARS-CoV-2 worldwide. The UK strictly-Orthodox Jewish community has been severely affected by the pandemic. This group shares characteristics with other ethnic minorities including larger family sizes, higher rates of household crowding and relative socioeconomic deprivation. We studied a UK strictly-Orthodox Jewish population to understand transmission of COVID-19 within this community. METHODS: We performed a household-focused cross-sectional SARS-CoV-2 serosurvey between late-October and early December 2020 prior to the third national lockdown. Randomly-selected households completed a standardised questionnaire and underwent serological testing with a multiplex assay for SARS-CoV-2 IgG antibodies. We report clinical illness and testing before the serosurvey, seroprevalence stratified by age and sex. We used random-effects models to identify factors associated with infection and antibody titres. FINDINGS: A total of 343 households, consisting of 1,759 individuals, were recruited. Serum was available for 1,242 participants. The overall seroprevalence for SARS-CoV-2 was 64.3% (95% CI 61.6-67.0%). The lowest seroprevalence was 27.6% in children under 5 years and rose to 73.8% in secondary school children and 74% in adults. Antibody titres were higher in symptomatic individuals and declined over time since reported COVID-19 symptoms, with the decline more marked for nucleocapsid titres. INTERPRETATION: In this tight-knit religious minority population in the UK, we report one of the highest SARS-CoV-2 seroprevalence levels in the world to date, which was markedly higher than the reported 10% seroprevalence in London at the time of the study. In the context of this high force of infection, all age groups experienced a high burden of infection. Actions to reduce the burden of disease in this and other minority populations are urgently required. FUNDING: This work was jointly funded by UKRI and NIHR [COV0335; MR/V027956/1], a donation from the LSHTM Alumni COVID-19 response fund, HDR UK, the MRC and the Wellcome Trust. Elsevier 2021-05-18 /pmc/articles/PMC8291041/ /pubmed/34308409 http://dx.doi.org/10.1016/j.lanepe.2021.100127 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Gaskell, Katherine M
Johnson, Marina
Gould, Victoria
Hunt, Adam
Stone, Neil RH
Waites, William
Kasstan, Ben
Chantler, Tracey
Lal, Sham
Roberts, Chrissy H.
Goldblatt, David
Eggo, Rosalind M
Marks, Michael
SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title_full SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title_fullStr SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title_full_unstemmed SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title_short SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
title_sort sars-cov-2 seroprevalence in a strictly-orthodox jewish community in the uk: a retrospective cohort study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/
https://www.ncbi.nlm.nih.gov/pubmed/34308409
http://dx.doi.org/10.1016/j.lanepe.2021.100127
work_keys_str_mv AT gaskellkatherinem sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT johnsonmarina sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT gouldvictoria sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT huntadam sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT stoneneilrh sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT waiteswilliam sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT kasstanben sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT chantlertracey sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT lalsham sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT robertschrissyh sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT goldblattdavid sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT eggorosalindm sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy
AT marksmichael sarscov2seroprevalenceinastrictlyorthodoxjewishcommunityintheukaretrospectivecohortstudy